Literature DB >> 22244608

Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.

Ottavio Rena1, Caterina Casadio.   

Abstract

The effects on long-term post-operative quality of life (QoL) and disease-control in malignant pleural mesothelioma (MPM) of extrapleural pneumonectomy (EPP) and pleurectomy/decortication (P/D) are compared. Seventy-seven patients affected by early-stage MPM received EPP (40) or P/D (37) associated with multimodal treatment between 1998 and 2009 at our institution. The last consecutive 39 (19 EPP and 20 P/D) were asked to answer the EORTC-QLQ-C30 questionnaire at baseline and at 6- and 12-months after treatment completion to evaluate the impact on QoL of both procedures. QoL evaluation was stopped at recurrence demonstration. Twenty-five (62%) EPP vs 9 (24%) P/D patients (p = 0.002) had in-hospital major complications, and 2/40 (5%) EPP vs no one P/D patients died after surgery. Both procedures caused a significant impairment of all the considered variables of the EORTC-QLQ-C30 questionnaire after treatment completion; only P/D patients returned at baseline levels after 12 months. EPP patients had a worse long-term post-operative QoL when compared with P/D. Median post-operative disease-free period was longer for EPP patients (14 vs 11 months) whereas the residual life to death period after recurrence detection was significantly longer for P/D patients (13 vs 9 months) (p = 0.01). Median long-term survival was longer, even not significant, for P/D patients (25 vs 20 months). MPM patients submitted to EPP had a higher post-operative complication rate, a worse long-term QoL, a shorter residual life time after recurrent disease, despite a similar long-term survival when compared to P/D.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22244608     DOI: 10.1016/j.lungcan.2011.12.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  30 in total

1.  Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?

Authors:  Nico van Zandwijk; Glen Reid; Anthony Linton; Steven Kao
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 2.  Overview of treatment related complications in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

3.  The impact of surgical approach on quality of life for pleural malignant mesothelioma.

Authors:  Rebecca M Schwartz; Alexis Watson; Andrea Wolf; Raja Flores; Emanuela Taioli
Journal:  Ann Transl Med       Date:  2017-06

4.  Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.

Authors:  Teruhisa Takuwa; Masaki Hashimoto; Seiji Matsumoto; Nobuyuki Kondo; Kozo Kuribayash; Takashi Nakano; Seiki Hasegawa
Journal:  Int J Clin Oncol       Date:  2017-04-24       Impact factor: 3.402

5.  Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.

Authors:  Dimitrios E Magouliotis; Vasiliki S Tasiopoulou; Kalliopi Athanassiadi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-10-29

Review 6.  Extended pleurectomy decortication: the current role.

Authors:  Rocco Bilancia; Marco Nardini; David A Waller
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 7.  Extrapleural pneumonectomy: still indicated?

Authors:  Andreas Domen; Lawek Berzenji; Jeroen M H Hendriks; Suresh Krishan Yogeswaran; Patrick Lauwers; Jan P Van Meerbeeck; Paul E Van Schil
Journal:  Transl Lung Cancer Res       Date:  2018-10

Review 8.  Management of malignant pleural mesothelioma-The European experience.

Authors:  Isabelle Opitz
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

9.  Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma.

Authors:  Alberto Sandri; Francesco Guerrera; Matteo Roffinella; Stefania Olivetti; Lorena Costardi; Alberto Oliaro; Pier Luigi Filosso; Paolo Olivo Lausi; Enrico Ruffini
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 10.  Current surgical strategies for malignant pleural mesothelioma.

Authors:  Teruhisa Takuwa; Seiki Hasegawa
Journal:  Surg Today       Date:  2015-11-21       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.